Last reviewed · How we verify
NCT07295704
Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema
trial testing Micropulse Laser in Micropulse Laser in 50 participants. Currently enrolling.
30 March 2026
Quick facts
| Lead sponsor | The General Authority for Teaching Hospitals and Institutes |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 15 October 2025 |
| Primary completion | 30 March 2026 |
| Estimated completion | 30 March 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Micropulse Laser
Conditions studied
- Micropulse Laser — all drugs for Micropulse Laser →
- Treatment — all drugs for Treatment →
- Initial — all drugs for Initial →
- Refractory — all drugs for Refractory →
Sponsor
The General Authority for Teaching Hospitals and Institutes
Who can join
18 and older, any sex, with Micropulse Laser or Treatment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effect of subthreshold 577 nm micropulse laser photocoagulation in the treatment of initial and refractory cases of Center-Involved Diabetic Macular Edema.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07295704
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Micropulse Laser
Trials testing the same drug.
- NCT03690947 — Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME · Phase 4 · completed
- NCT03143192 — Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser · Phase 2, PHASE3 · completed
Other The General Authority for Teaching Hospitals and Institutes trials
Trials by the same sponsor.
- NCT07295691 — Autologous Serum Eye Drops in Dry Eye Syndrome · NA · recruiting
- NCT07125794 — Original Denis Brawn Brace Versus Its Modification for Management of Relapsed Idiopathic Clubfoot Following Ponseti Cast · recruiting
- NCT07108712 — Diffusion Magnetic Resonance Imaging (dMRI) in the Early Evaluation of Brain White Matter Diseases · recruiting
- NCT07108725 — Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction · recruiting
- NCT06928844 — Role of Low Dose Injectable Progesterone in Triggering Ovulation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07295704 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The General Authority for Teaching Hospitals and Institutes
- Last refreshed: 22 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07295704.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing